DONACO INTERNATIONAL LIMITED (DNA)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

DNA - DONACO INTERNATIONAL LIMITED

FNArena Sector : NONE
Year End: June
GICS Industry Group : Consumer Services
Debt/EBITDA: 1.37
Index:

LAST PRICE CHANGE +/- CHANGE % VOLUME

$0.03

08 Oct
2024

-0.003

OPEN

$0.03

-9.09%

HIGH

$0.03

172,472

LOW

$0.03

FNARENA'S MARKET CONSENSUS FORECASTS

- No Record -

Last ex-div: 05/10 - (franking ex-di

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title 201920202021202220232024
EPS Basic xxxxxxxxxxxxxxx3.0
DPS All xxxxxxxxxxxxxxx0.0
Sales/Revenue xxxxxxxxxxxxxxx39.5 M
Book Value Per Share xxxxxxxxxxxxxxx12.3
Net Operating Cash Flow xxxxxxxxxxxxxxx15.0 M
Net Profit Margin xxxxxxxxxxxxxxx93.76 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 201920202021202220232024
Return on Capital Employed xxxxxxxxxxxxxxx27.18 %
Return on Invested Capital xxxxxxxxxxxxxxx25.64 %
Return on Assets xxxxxxxxxxxxxxx19.37 %
Return on Equity xxxxxxxxxxxxxxx27.18 %
Return on Total Capital xxxxxxxxxxxxxxx9.71 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx14.7 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 201920202021202220232024
Short-Term Debt xxxxxxxxxxxxxxx16 M
Long Term Debt xxxxxxxxxxxxxxx7 M
Total Debt xxxxxxxxxxxxxxx23 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx29 M
Price To Book Value xxxxxxxxxxxxxxx0.26

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 201920202021202220232024
Capex xxxxxxxxxxxxxxx0.3 M
Capex % of Sales xxxxxxxxxxxxxxx0.84 %
Cost of Goods Sold xxxxxxxxxxxxxxx17 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx7 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.0

No. Of Recommendations

0
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

DNA STOCK CHART